Journal article

Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease

Thomas J Telfer, Jeffrey R Liddell, Clare Duncan, Anthony R White, Rachel Codd

Bioorganic & Medicinal Chemistry Letters | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2017

DOI: 10.1016/j.bmcl.2017.03.001

Citation metrics

6Web of Science
7Scopus
6Dimensions

Keywords

Pharmacology & Pharmacy
Iron
Cell Survival
Chemistry
Chemistry, Organic
Chemistry, Medicinal
Science & Technology
Derivatives
Cells, Cultured
Polycyclic Compounds
Parkinson'S Disease
Parkinson’s Disease
Physical Sciences
Overload
Humans
Deferoxamine
Life Sciences & Biomedicine
Iron Chelators
Hydrophobicity Parameters
Astrocytes
Iron Chelating Agents
Desferrioxamine B
Polycyclic Cage Compounds
Cell Line
Parkinson Disease